GLAXOSMITHKLINE PHARMACEUTICALS LTD. - Closure of Trading Window

GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the restricted trading period in terms of the Share Dealing Code formulated and adopted by the Company under the SEBI (Prohibition of Insider Trading) Regulations, as amended, has started from April 01, 2015 and shall end 24 hours after declaration of Audited / Unaudited Financial Results (FY 2014- 2015).